Cart
sales@molnova.com
LEE011
CAS No. 1211441-98-3
LEE011 ( Ribociclib )
Catalog No. M10790 CAS No. 1211441-98-3
LEE011 is an orally available, and highly specific CDK4/6 inhibitor. Phase 3.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 32 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 93 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | 161 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLEE011
-
NoteResearch use only, not for human use.
-
Brief DescriptionLEE011 is an orally available, and highly specific CDK4/6 inhibitor. Phase 3.
-
DescriptionLEE011 is an orally available, and highly specific CDK4/6 inhibitor. Phase 3.
-
SynonymsRibociclib
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK4
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1211441-98-3
-
Formula Weight434.54
-
Molecular FormulaC23H30N8O
-
Purity>98%(HPLC)
-
SolubilityDMSO: 7 mg/mL (16.1 mM)
-
SMILESCN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N1C1CCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rader J, et al. Clin Y Res. 2013, 19(22), 6173-6182.
molnova catalog
related products
-
CDKI-73
CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM, shows cytotoxicity against a broad CLL samples with mean LD50 of 80 nM.
-
ON123300
ON123300 is a potent, multi-targeted kinase inhibitor with IC50 of 5, 3.9, 26, 26, 9.2 and 11 nM for ARK5, CDK4, PDGFRβ, FGFR1, RET and FYN, respectively.
-
BQU57
BQU57 shows selective inhibition for Ral relative to Ras or Rho and inhibit xenograft tumor growth.
